MAX Chat
China Resources Pharmaceutical Group Limited
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
9/10
|
9.89 | 37.2 | -73.42% | 8.69 | +13.73% |
| P/S |
|
0.1286 | 4.03 | -96.81% |
|
|
| P/BV |
|
0.3377 | 1.93 | -82.54% |
|
|
| P/FCF |
|
2.46 | -10.12 | -124.3% |
|
|
| Ev/Ebitda |
|
4.65 | 2.91 | 59.87% |
|
|
| Ev/S |
|
0.3276 | 7.34 | -95.53% |
|
|
| Ev/FCF |
|
5.89 | -11 | -153.53% |
|
|
| E/P |
|
0.0951 | 0.0327 | 190.4% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
2/10
|
6.16 | 1.46 | 321.66% | 5.97 | +3.14% |
| ROE |
|
7.11 | 3.98 | 78.94% |
|
|
| ROA |
|
1.33 | 2.89 | -54% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
1.3 | 10.86 | -88.03% |
|
|
| ROCE |
|
0 | 0.1527 | -100% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
2/10
|
4.27 | 0.3827 | 1015.69% | 3.37 | +26.51% |
| Nеt Debt/Ebitda |
|
3.23 | -0.2202 | -1568.97% |
|
|
| Debt/Ratio |
|
0.2627 | 0.132 | 99% |
|
|
| Debt/Equity |
|
1.63 | 0.6875 | 136.77% |
|
|
| Debt/Net Income |
|
20.21 | 2.61 | 674.97% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
10/10
|
4.16 | 4.32 | -3.61% | 3.29 | +26.5% |
| Number of years of dividend growth |
|
3 | 1.23 | 144.07% | ||
| DSI |
|
0.8571 | 0.5482 | 56.36% |
|
|
| Average dividend growth |
|
12.81 | -2.77 | -562.1% |
|
|
| Average percentage for 5 years |
|
3.29 | 4.29 | -23.3% |
|
|
| Average percentage for payments |
|
23.04 | 34.1 | -32.42% |
|
|
| Difference from average difference in sector |
|
-0.1556 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
4/10
|
28.56 | -94.75 | -130.14% | ||
| Growth impulse Ebitda in 5 years |
|
4.42 | -45.56 | -109.7% | ||
| Growth impulse Net Income in 5 years |
|
1.63 | -111.86 | -101.46% | ||
| Growth impulse FCF in 5 years |
|
139.36 | -138.06 | -200.94% | ||
| Growth impulse EPS in 5 years |
|
2.57 | -139.77 | -101.84% |
IP Score
5.02/10
